Clinical trial
Omega-3 Fatty Acids in Bipolar Disorder
NCT00010868 · National Center for Complementary and Integrative Health (NCCIH), NIH · Completed
Key facts
| NCT number | NCT00010868 |
|---|---|
| Title | Omega-3 Fatty Acids in Bipolar Disorder |
| Official title | Omega-3 Fatty Acids in Bipolar Disorder Prophylaxis |
| Lead sponsor | National Center for Complementary and Integrative Health (NCCIH), NIH |
| Collaborators | Pronova BioPharma Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Bipolar Disorder |
| Intervention type | Drug |
| Interventions | Omega-3 Fatty Acids |
| Start date | Jul 1, 2000 |
| Completion | Jul 1, 2004 |
| First posted | Feb 5, 2001 |
| Last update posted | Aug 18, 2006 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: